Literature DB >> 15128072

Abnormal expression of E-cadherin in early gastric carcinoma: its relationship with macroscopic growth patterns and catenin alpha and beta.

Sang Yong Song1, Seonwoo Kim, Dae Shick Kim, Hee Jung Son, Jong Chul Rhee, Yong Il Kim.   

Abstract

BACKGROUND: Abnormal expression of E-cadherin plays an important role in the differentiation and progression of gastric carcinoma. There are a few identifiable clinical, histopathologic, and molecular changes that are related with the macroscopic growth patterns of gastric carcinoma. The aim of this study is to elucidate the relation between the macroscopic growth patterns of gastric carcinoma and the abnormal expression of E-cadherin, alpha- and beta-catenins. STUDY: A total of 97 cases of early gastric carcinoma were examined by immunohistochemistry using monoclonal antibodies against E-cadherin, alpha- and beta-catenins. Macroscopically, 52 cases were elevated types and 45 cases were depressed types.
RESULTS: Early gastric carcinomas with depressed growth showed diffuse histologic type, younger patients' age and smaller size more frequently than tumors with elevated growth. Abnormal expression rates of E-cadherin, alpha- and beta-catenins were 35.1, 36.1, and 46.4%, respectively. Abnormal expression of E-cadherin, alpha- and beta-catenins was significantly associated with depressed tumor growth and diffuse histologic type. By multiple logistic regression analysis. E-cadherin, age, Lauren classification, World Health Organization grade and size were identified as risk factors of macroscopic growth pattern of early gastric carcinomas. Positive associations between E-cadherin and beta-catenin and between alpha- and beta-catenins were found by log linear model analysis.
CONCLUSION: We suggest that E-cadherin plays an important role in the macroscopic growth as well as microscopic differentiation of early gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128072     DOI: 10.1097/00004836-200403000-00011

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  3 in total

1.  Clinical implications of CTNNA1 germline mutations in asymptomatic carriers.

Authors:  Patrick R Benusiglio; Chrystelle Colas; Erell Guillerm; Axelle Canard; Hélène Delhomelle; Mathilde Warcoin; Jérôme Bellanger; Mélanie Eyries; Mohamed Zizi; Jeanne Netter; Florent Soubrier; Yann Parc; Anne Mourregot; Aurélie Maran Gonzalez; Veronica Cusin; Jérôme A Denis; Isabelle Coupier; Magali Svrcek; Florence Coulet
Journal:  Gastric Cancer       Date:  2018-12-04       Impact factor: 7.370

2.  Association between common genetic variants in pre-microRNAs and the clinicopathological characteristics and survival of gastric cancer patients.

Authors:  Masaaki Okubo; Tomomitsu Tahara; Tomoyuki Shibata; Hiromi Yamashita; Masakatsu Nakamura; Daisuke Yoshioka; Joh Yonemura; Yoshio Kamiya; Takamitsu Ishizuka; Yoshihito Nakagawa; Mitsuo Nagasaka; Masami Iwata; Tomiyasu Arisawa; Ichiro Hirata
Journal:  Exp Ther Med       Date:  2010-09-29       Impact factor: 2.447

Review 3.  Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis.

Authors:  Jacqueline M Benjamin; W James Nelson
Journal:  Semin Cancer Biol       Date:  2007-09-04       Impact factor: 15.707

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.